Related Experiment Video

Updated: May 14, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

The p53/microRNA network in cancer: experimental and bioinformatics approaches

Sabine Hünten1, Helge Siemens, Markus Kaller

  • 1Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.

Advances in Experimental Medicine and Biology
|February 5, 2013
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of tumor suppression by p53. This review details their mechanisms, identification, and roles in cancer, highlighting miR-34 and miR-200 families.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are increasingly recognized as critical regulators in cellular signaling pathways.
  • The tumor suppressor protein p53 plays a central role in maintaining genomic stability and preventing cancer.
  • Emerging evidence highlights the intricate interplay between p53 and miRNAs in cancer biology.

Purpose of the Study:

  • To review the fundamental mechanisms by which miRNAs contribute to p53-mediated tumor suppression.
  • To summarize the current understanding of the p53-miRNA axis and its alterations in cancer.
  • To describe experimental and bioinformatics methodologies for investigating p53-miRNA interactions.

Main Methods:

  • Literature review and synthesis of existing research findings.
  • Analysis of experimental data and bioinformatics approaches.
  • Discussion of identified miRNA-encoding genes and pathways.

Main Results:

  • MiRNAs are integral components of p53's tumor suppressive signaling cascades.
  • Specific miRNA families, such as miR-34 and miR-200, are key mediators of p53 function.
  • Dysregulation of p53/miRNA pathways is observed in various cancers.

Conclusions:

  • The p53-miRNA network is a crucial determinant of tumor suppression.
  • Further research is needed to fully elucidate the complex interactions within the p53-miRNA axis.
  • Understanding these pathways offers potential for novel cancer therapeutic strategies.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...